Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€4.08

€4.08

-0.490%
-0.02
-0.490%
€3.50

€3.50

 
22.10.21 / Frankfurt WKN: A14VMC / Name: Celyad / Stock / Biotechnology & Medical Research / Small Cap /
Latest predictions
19.09.21
13.97%
€3.50
23.06.21
-4.23%
Your prediction

Celyad SA ADR Stock

Celyad SA ADR shows a slight decrease today, losing -€0.020 (-0.490%) compared to yesterday.
The community is currently still undecided about Celyad SA ADR with 0 Buy predictions and 2 Sell predictions.
This results in a negative potential of -26.471% based on a current price of €4.08 and a target price of €3.00 for the stock.
For the coming years our community has positive and negative things to say abot the Celyad SA ADR stock. Criterium "Worthwhile Investment for the next years" gathered the most positive votes but regarding "Worthwhile Investment for the next years" there were negative voices in the community.

Pros and Cons of Celyad SA ADR in the next few years

Pros
0
-
Cons
1
Probably not worthwhile Investment

Performance of Celyad SA ADR vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
Celyad SA ADR -0.490% - - - - - -
Cardio3 Biosciences S.A. -4.680% 11.491% 16.762% -42.034% -36.526% -81.921% -75.017%
Mdxhealth -1.270% -1.266% -4.878% 47.541% 37.002% - -
Oxurion NV 0.450% -5.957% 20.633% -15.970% -14.836% -56.751% -22.183%

Other discussions about Celyad SA ADR Stock

New thread Forum